Individuals who have or are at risk for knee osteoarthritis and indicate experiencing high neuropathic-like pain, may have central pain sensitization.
Low-dose radiotherapy may represent an effective treatment for the relief of pain and the improvement of musculoskeletal function in patients with lateral or medial epicondylitis, finger osteoarthritis, or plantar fasciitis who are resistant to therapy.
Poor sleep quality was linked to increased pain and fatigue in older adults with symptomatic osteoarthritis.
Gabapentin and duloxetine were found to provide comparable analgesia and improvement in functional status in patients with knee osteoarthritis after 3 months of treatment.
Investigators examined how peripheral and central sensitization, important osteoarthritis pain mechanisms, are associated with self-reported hand pain.
Pain may be the primary driver for the use of health care services in patients with osteoarthritis.
Daily measurements of pain in patients with hip osteoarthritis may not be more precise than retrospective measurements.
Cyclooxygenase-2 inhibitor therapy should be cautiously used in patients with osteoarthritis due to an increased risk for gastrointestinal- and cardiovascular-related adverse events.
Patient demographics, prior lower back injury, and the presence of hip osteoarthritis (OA) may have an effect on lumbar spine OA phenotype.
Investigators studied the relationship among bone marrow lesions, bone mineral density, and bone markers in women without radiographic evidence of knee osteoarthritis.